Source 1review2020Nature Reviews Microbiology
Toolkit/bacterial cellulose
bacterial cellulose
Also known as: BC
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The supplied review scaffold states that the anchor review places explicit emphasis on exopolysaccharides such as alginate, cellulose, and hyaluronate, and separately identifies bacterial cellulose (BC) as a strongest explicitly supported component name.
Usefulness & Problems
Why this is useful
Bacterial cellulose is presented as a bacterial biopolymer class relevant to the review's transition from pathogenesis to advanced materials. The supplied scaffold specifically flags it as a major component name supported by the anchor review.; advanced materials; biomedical applications; bacterial biopolymer-based materials; Bacterial cellulose is presented as a pure, crystalline biomaterial produced by aerobic bacteria and used as a standalone or composite material. The review frames it as a platform for biomedical device and material development.; biomedical material development; wound care applications; organ regeneration applications; disease diagnosis applications; drug transportation applications; forming pure or composite biomaterials
Source:
Bacterial cellulose is presented as a bacterial biopolymer class relevant to the review's transition from pathogenesis to advanced materials. The supplied scaffold specifically flags it as a major component name supported by the anchor review.
Source:
advanced materials
Source:
biomedical applications
Source:
bacterial biopolymer-based materials
Source:
Bacterial cellulose is presented as a pure, crystalline biomaterial produced by aerobic bacteria and used as a standalone or composite material. The review frames it as a platform for biomedical device and material development.
Source:
biomedical material development
Source:
wound care applications
Source:
organ regeneration applications
Source:
disease diagnosis applications
Source:
drug transportation applications
Source:
forming pure or composite biomaterials
Problem solved
It serves as a biologically produced polymer platform for materials and biomedical-use discussions within the review's scope.; provides a bacterial polymer platform for materials-oriented applications; It provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.; provides a highly pure and crystalline cellulose-based material for biomedical engineering; serves as a platform material that can be combined with biopolymers or nanoparticles to create innovative biomaterials
Source:
It serves as a biologically produced polymer platform for materials and biomedical-use discussions within the review's scope.
Source:
provides a bacterial polymer platform for materials-oriented applications
Source:
It provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.
Source:
provides a highly pure and crystalline cellulose-based material for biomedical engineering
Source:
serves as a platform material that can be combined with biopolymers or nanoparticles to create innovative biomaterials
Problem links
provides a bacterial polymer platform for materials-oriented applications
LiteratureIt serves as a biologically produced polymer platform for materials and biomedical-use discussions within the review's scope.
Source:
It serves as a biologically produced polymer platform for materials and biomedical-use discussions within the review's scope.
provides a highly pure and crystalline cellulose-based material for biomedical engineering
LiteratureIt provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.
Source:
It provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.
serves as a platform material that can be combined with biopolymers or nanoparticles to create innovative biomaterials
LiteratureIt provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.
Source:
It provides a cellulose-based material with properties of interest for wound care, regeneration, diagnosis, and drug transportation. The review positions it as a basis for innovative biomedical materials.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
bacterial exopolysaccharide biosynthesismaterial compositing with biopolymers or nanoparticlesTechniques
No technique tags yet.
Target processes
No target processes tagged yet.
Input: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: payload burdenoperating role: actuator
Use of bacterial cellulose as a material depends on bacterial production and application-specific processing, but the present payload does not provide protocol details.; requires bacterial production context and downstream material-processing details not provided in this payload; Its production requires aerobic bacterial cultivation. Composite implementations may additionally require biopolymers or nanoparticles.; generated by aerobic bacteria; composite use may require combination with biopolymers or nanoparticles
The available evidence does not establish a specific engineering workflow, delivery mode, or comparative benchmark against other material platforms.; the provided payload does not include the anchor review abstract or full-text details needed to specify performance tradeoffs; The abstract does not show that BC alone solves commercialization or all biomedical performance requirements. It explicitly notes that further investigation is needed before it becomes marketable in vital biomaterials.; further investigations are required to make it marketable in vital biomaterials
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2review2017Nanomaterials
Ranked Claims
The review covers exopolysaccharides such as alginate, cellulose, and hyaluronate.
The review covers intracellular or storage and functional polymers including polyhydroxyalkanoates and polyphosphate.
The review covers proteinaceous biofilm components such as amyloids, including curli.
The review states that bacterial cellulose can be used alone or with other components such as biopolymers and nanoparticles for a wide range of applications including biomedical products.
The review states that bacterial cellulose has potential applications in wound care, organ regeneration, disease diagnosis, and drug transportation.
Bacterial cellulose is described in the review abstract as a highly pure and crystalline material produced by aerobic bacteria.
The review concludes that further investigations are required to make bacterial cellulose marketable in vital biomaterials.
Approval Evidence
2 sources5 linked approval claimsfirst-pass slug bacterial-cellulose
The supplied review scaffold states that the anchor review places explicit emphasis on exopolysaccharides such as alginate, cellulose, and hyaluronate, and separately identifies bacterial cellulose (BC) as a strongest explicitly supported component name.
Source:
Bacterial cellulose (BC) is a highly pure and crystalline material generated by aerobic bacteria... BC, alone or in combination with different components (e.g., biopolymers and nanoparticles), can be used for a wide range of applications... Bacterial cellulose has potential applications across several medical sectors and permits the development of innovative materials.
Source:
topic coveragesupports
The review covers exopolysaccharides such as alginate, cellulose, and hyaluronate.
Source:
application scopesupports
The review states that bacterial cellulose can be used alone or with other components such as biopolymers and nanoparticles for a wide range of applications including biomedical products.
Source:
biomedical application summarysupports
The review states that bacterial cellulose has potential applications in wound care, organ regeneration, disease diagnosis, and drug transportation.
Source:
property summarysupports
Bacterial cellulose is described in the review abstract as a highly pure and crystalline material produced by aerobic bacteria.
Source:
translation gapsupports
The review concludes that further investigations are required to make bacterial cellulose marketable in vital biomaterials.
Source:
Comparisons
Source-stated alternatives
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.; The abstract contrasts BC with plant cellulose by noting unique physicochemical characteristics. It also notes use in combination with other components such as biopolymers and nanoparticles.
Source:
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.
Source:
The abstract contrasts BC with plant cellulose by noting unique physicochemical characteristics. It also notes use in combination with other components such as biopolymers and nanoparticles.
Source-backed strengths
explicitly highlighted as a major polymer class in the review's pathogenesis-to-materials framing; described as highly pure; described as crystalline; usable in both pure and composite forms; applicable across multiple biomedical sectors
Source:
explicitly highlighted as a major polymer class in the review's pathogenesis-to-materials framing
Source:
described as highly pure
Source:
described as crystalline
Source:
usable in both pure and composite forms
Source:
applicable across multiple biomedical sectors
Compared with alginate
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly highlighted as a major polymer class in the review's pathogenesis-to-materials framing; described as highly pure; described as crystalline.
Relative tradeoffs: the provided payload does not include the anchor review abstract or full-text details needed to specify performance tradeoffs; further investigations are required to make it marketable in vital biomaterials.
Source:
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.
Compared with polyhydroxyalkanoates
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly highlighted as a major polymer class in the review's pathogenesis-to-materials framing; described as highly pure; described as crystalline.
Relative tradeoffs: the provided payload does not include the anchor review abstract or full-text details needed to specify performance tradeoffs; further investigations are required to make it marketable in vital biomaterials.
Source:
The supplied scaffold places bacterial cellulose alongside alginate, polyhydroxyalkanoates, and other bacterial biopolymers as adjacent material-relevant alternatives.
Ranked Citations
- 1.
- 2.